CONMED Corporation
CNMD
$34.51
-$0.26-0.75%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.14% | 5.18% | 4.61% | 3.94% | 4.32% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.14% | 5.18% | 4.61% | 3.94% | 4.32% |
| Cost of Revenue | 9.47% | 10.54% | 3.33% | 2.05% | 2.61% |
| Gross Profit | 0.01% | 0.99% | 5.62% | 5.43% | 5.68% |
| SG&A Expenses | 4.75% | 7.08% | 7.20% | 5.79% | 4.68% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.34% | 8.60% | 4.82% | 3.61% | 3.43% |
| Operating Income | -20.19% | -19.44% | 2.98% | 6.45% | 11.56% |
| Income Before Tax | -43.70% | -56.38% | -46.58% | 11.13% | 39.96% |
| Income Tax Expenses | 1.59% | -21.38% | -24.34% | 8.65% | 23.66% |
| Earnings from Continuing Operations | -53.81% | -64.47% | -51.37% | 11.77% | 44.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -53.81% | -64.47% | -51.37% | 11.77% | 44.20% |
| EBIT | -20.19% | -19.44% | 2.98% | 6.45% | 11.56% |
| EBITDA | -12.46% | -12.34% | 2.88% | 4.99% | 7.83% |
| EPS Basic | -53.80% | -64.59% | -51.56% | 11.32% | 43.61% |
| Normalized Basic EPS | -21.91% | -21.19% | 7.95% | 12.02% | 18.82% |
| EPS Diluted | -53.41% | -64.38% | -51.31% | 12.39% | 45.55% |
| Normalized Diluted EPS | -21.52% | -20.71% | 8.98% | 13.57% | 21.03% |
| Average Basic Shares Outstanding | -0.08% | 0.38% | 0.48% | 0.49% | 0.51% |
| Average Diluted Shares Outstanding | -0.61% | -0.28% | -0.47% | -0.88% | -1.38% |
| Dividend Per Share | -50.00% | -25.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 0.63% | 1.83% | 1.07% | -0.10% | -0.30% |